QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug ...
The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results